Journal article
Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial
The oncologist (Dayton, Ohio), Vol.25(9), pp.758-764
09/2020
DOI: 10.1634/theoncologist.2019-0805
PMID: 32476183
Abstract
Despite remarkable achievements in breast cancer research, little attention has been paid to the sequence of chemotherapy agents in breast cancer treatment. This article compares an anthracycline‐based followed by a taxane neoadjuvant chemotherapy regimen with the reverse sequence in patients with locally advanced, HER2‐negative invasive breast cancer.
Details
- Title: Subtitle
- Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial
- Creators
- José Bines - Medical Oncology, Instituto Nacional de CâncerIsabele A Small - Clinical Research, Instituto Nacional de CâncerRoberta Sarmento - Clinical Research, Instituto Nacional de CâncerFabiola Kestelman - University of Iowa, RadiologySilvania Silva - Clinical Research, Instituto Nacional de CâncerFabiana Resende Rodrigues - Pathology, Instituto Nacional de CâncerLilian Faroni - Radiation Oncology, Instituto Nacional de CâncerAline Gonçalves - Medical Oncology, Instituto Nacional de CâncerErika Ebecken - Medical Oncology, Instituto Nacional de CâncerPedro Maroun - Surgery, Instituto Nacional de CâncerEduardo Millen - Surgery, Instituto Nacional de CâncerMartin Bonamino - Immunology and Tumor Biology Program ‐ Research Coordination, Instituto Nacional de Câncer
- Resource Type
- Journal article
- Publication Details
- The oncologist (Dayton, Ohio), Vol.25(9), pp.758-764
- DOI
- 10.1634/theoncologist.2019-0805
- PMID
- 32476183
- NLM abbreviation
- Oncologist
- ISSN
- 1083-7159
- eISSN
- 1549-490X
- Publisher
- John Wiley & Sons, Inc
- Alternative title
- The Sequence of Anthracycline and Taxane
- Language
- English
- Date published
- 09/2020
- Academic Unit
- Radiology
- Record Identifier
- 9984119796502771
Metrics
28 Record Views